Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Bunse, Mario Dr. (1) Clauß, Julian (1) Costanza, Mariantonia Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kieback, Elisa Dr. (1) Kirchner, Marieluise Dr. (2) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Mathas, Stephan Dr. (1) Na, Il-Kang Dr. (1) Rehm, Armin Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (2) Uyar, Bora Dr. (1) Willimsky, Gerald Dr. (3) Willnow, Thomas Prof. Dr. (1) Zauber, Henrik Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (4) (-) Janz, Martin Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) 1992 (4) 1993 (7) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) 2000 (9) 2002 (6) 2003 (12) 2004 (10) 2005 (12) 2007 (7) 2008 (7) 2010 (8) 2011 (9) 2012 (8) 2013 (13) 2017 (9) (-) 2018 (5) 2019 (6) 2021 (7) 2022 (10) 2023 (10) 2024 (3) (-) Biology of Malignant Lymphomas (1) Immune Dysregulations in Oncology (1) Immune Regulation and Cancer (1) (-) Molecular Immunology and Gene Therapy (4) Systems Biology of Gene Regulatory Elements (1) 5 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biology of Malignant LymphomasMolecular Immunology and Gene Therapy2018 Sort: Result score Newest to oldest Oldest to newest August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas August 01, 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein January 01, 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na
August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
September 01, 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
August 01, 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
January 01, 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na